期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease 被引量:1
1
作者 Vijairam Selvaraj Amos Lal +5 位作者 Arkadiy Finn Joshua Ray Tanzer Muhammad Baig Atin Jindal kwame dapaah-afriyie George Bayliss 《World Journal of Critical Care Medicine》 2022年第1期48-57,共10页
BACKGROUND Since the beginning of corona virus disease 2019(COVID-19)pandemic,there has been a widespread use of remdesivir in adults and children.There is little known information about its outcomes in patients with ... BACKGROUND Since the beginning of corona virus disease 2019(COVID-19)pandemic,there has been a widespread use of remdesivir in adults and children.There is little known information about its outcomes in patients with end stage renal disease who are on dialysis.AIM To assess the clinical outcomes with use of remdesivir in adult patients with end stage kidney failure on hemodialysis.METHODS A retrospective,multicenter study was conducted on patients with end stage renal disease on hemodialysis that were discharged after treatment for COVID-19 between April 1,2020 and December 31,2020.Primary endpoints were oxygen requirements,time to mortality and escalation of care needing mechanical ventilation.RESULTS A total of 45 patients were included in the study.Twenty patients received remdesivir,and 25 patients did not receive remdesivir.Most patients were caucasian,females with diabetes mellitus and hypertension being the commonest comorbidities.There was a trend towards reduced oxygen requirement(beta=-25.93,X^(2)(1)=6.65,P=0.0099,probability of requiring mechanical ventilation(beta=-28.52,X^(2)(1)=22.98,P<0.0001)and mortality(beta=-5.03,X^(2)(1)=7.41,P=0.0065)in patients that received remdesivir compared to the control group.CONCLUSION Larger studies are justified to study the effects of remdesivir in this high-risk population with end stage kidney disease on dialysis. 展开更多
关键词 COVID-19 Remdesivir End stage renal disease DIALYSIS HEMODIALYSIS Kidney disease
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部